Navigation Links
Boca Pharmacal Receives FDA Approval for Carbinoxamine Oral Solution
Date:2/27/2008

CORAL SPRINGS, Fla., Feb. 27 /PRNewswire/ -- Boca Pharmacal, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Pamlab's Palgic(R) Oral Solution (Carbinoxamine Maleate Oral Solution) 4 mg/5mL. The Company plans to launch its product immediately.

Carbinoxamine Maleate Oral Solution 4mg/5mL is indicated to treat seasonal and perennial allergic rhinitis.

"This approval is another example of our commitment to providing affordable drug products to customers and consistent innovation in the pharmaceutical industry," commented Robert J. Edwards Jr., CEO. "At Boca Pharmacal we pride ourselves on our ability to offer lower volume items that may have been overlooked by some of the larger generic companies. Carbinoxamine Maleate Oral Solution is the first of many approvals we expect in 2008. Having filed multiple ANDA applications coupled with our multinational partnerships we expect 2008 to be a very big year."

Founded in 1998 Coral Springs, FL based Boca Pharmacal manufactures, develops and distributes a wide variety of generic drugs.


'/>"/>
SOURCE Boca Pharmacal, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mission Pharmacal Launches CitraNatal(TM) Prescription Prenatal Vitamin Line
2. Mission Pharmacal Congratulates Exemplary Womens Health Researchers
3. IDC receives patent on dual energy imaging technology
4. Kryptiq Customer Receives HIMSS Nicholas E. Davies Award of Excellence
5. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
6. Healthy Start of Southwest Florida Receives Grant From March of Dimes to Assess Needs of Pregnant Women and Babies
7. Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award
8. Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA
9. Florida Tissue Services Receives National Accreditation
10. Siemens Receives FDA Approval for the VERSANT 440 Molecular System
11. Global Med Technologies(R), Inc. Receives FDA 510(K) Clearance for ElDorado Donor(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: